Bio-Rad Laboratories, Inc. (BIO) Financial Statements (2024 and earlier)

Company Profile

Business Address 1000 ALFRED NOBEL DRIVE
HERCULES, CA 94547
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 3826 - Laboratory Analytical Instruments (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1,722,6861,851,4531,790,6721,850,1231,967,6592,073,479
Cash and cash equivalents390,001464,136434,215517,943596,584802,316
Short-term investments1,332,6851,387,3171,356,4571,332,1801,371,0751,271,163
Restricted cash and investments5,5605,5605,5605,5605,5605,560
Receivables491,575498,273494,645432,302450,324464,107
Inventory, net of allowances, customer advances and progress billings776,600752,937719,316685,850657,130605,492
Inventory776,600752,937719,316685,850657,130605,492
Prepaid expense122,641120,838124,179147,198130,534126,657
Other current assets19,80448,19123,60419,12238,49028,126
Total current assets:3,138,8663,277,2523,157,9763,140,1553,249,6973,303,421
Noncurrent Assets
Operating lease, right-of-use asset173,922174,096180,952171,587185,150198,453
Property, plant and equipment   498,612   
Long-term investments and receivables7,311,1358,878,5148,830,8927,459,1698,088,0029,689,284
Long-term investments7,311,1358,878,5148,830,8927,459,1698,088,0029,689,284
Intangible assets, net (including goodwill)740,229735,585738,635724,665587,070592,872
Goodwill411,519407,757406,488399,589347,323345,728
Intangible assets, net (excluding goodwill)328,710327,828332,147325,076239,747247,144
Restricted cash and investments398320 289  
Other noncurrent assets   94,599   
Other undisclosed noncurrent assets613,679601,647 562,597572,207589,668
Total noncurrent assets:8,839,36310,390,16210,343,6908,918,3079,432,42911,070,277
TOTAL ASSETS:11,978,22913,667,41413,501,66612,058,46212,682,12614,373,698
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities378,720385,759362,259586,214571,337399,502
Taxes payable29,27425,90854,309
Employee-related liabilities192,460180,631184,542
Accounts payable149,535160,979135,041142,746158,259160,651
Accrued liabilities229,185224,780227,218221,734206,539 
Deferred revenue   52,211   
Debt4765191,465448466504
Deferred compensation liability   1,200   
Other liabilities166,243167,196117,437171,706212,715211,586
Other undisclosed current liabilities36,54336,14934,136(187,691)(170,804)36,739
Total current liabilities:581,982589,623568,708570,677613,714648,331
Noncurrent Liabilities
Long-term debt and lease obligation, including:1,198,3841,198,0051,197,7161,344,4831,355,4721,366,473
Long-term debt, excluding current maturities1,198,3841,198,005 1,197,2721,196,9431,196,739
Finance lease, liability   10,100   
Other undisclosed long-term debt and lease obligation   1,187,616   
Liabilities, other than long-term debt1,750,9702,116,0702,119,9901,689,6971,790,3432,175,978
Deferred income tax liabilities1,401,8271,769,7811,770,4811,484,6061,613,5281,995,889
Other liabilities202,294199,249195,912205,091176,815180,089
Operating lease, liability146,849147,040153,597147,211158,529169,734
Total noncurrent liabilities:2,949,3543,314,0753,317,7063,034,1803,145,8153,542,451
Total liabilities:3,531,3363,903,6983,886,4143,604,8573,759,5294,190,782
Equity
Equity, attributable to parent, including:8,446,8939,763,7169,615,2528,453,6058,922,59710,182,916
Additional paid in capital473,872463,402447,454430,547471,863459,431
Accumulated other comprehensive loss(372,862)(408,352)(466,822)(845,214)(533,386)(307,856)
Retained earnings8,804,6649,966,9599,898,2039,046,5309,210,45710,137,628
Other undisclosed equity, attributable to parent(458,781)(258,293)(263,583)(178,258)(226,337)(106,287)
Total equity:8,446,8939,763,7169,615,2528,453,6058,922,59710,182,916
TOTAL LIABILITIES AND EQUITY:11,978,22913,667,41413,501,66612,058,46212,682,12614,373,698

Income Statement (P&L) ($ in thousands)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
Revenues681,110676,844730,239680,800691,099700,062
Cost of revenue
(Cost of Goods and Services Sold)
(318,627)(314,427)(336,291)(307,008)(295,118)(296,502)
Other undisclosed gross profit   49   
Gross profit:362,483362,417393,997373,792395,981403,560
Operating expenses(272,866)(300,504)(267,817)(280,996)(275,764)(260,137)
Operating income:89,61761,913126,18092,796120,217143,423
Nonoperating income (expense)17,74152,7785,543(1,302)5,81334,725
Gain (loss), foreign currency transaction, before tax1,2532,3473,338(4,364)(897)2,128
Other nonoperating income16,48850,4312,2053,0626,71032,597
Interest and debt expense(12,343)(12,337)(11,683)(11,663)(10,720)(4,048)
Income from continuing operations before equity method investments, income taxes:95,015102,354120,04079,831115,310174,100
Other undisclosed income (loss) from continuing operations before income taxes(1,595,442)(17,525)978,752(288,999)(1,338,190)(4,545,117)
Income (loss) from continuing operations before income taxes:(1,500,427)84,8291,098,792(209,168)(1,222,880)(4,371,017)
Income tax expense (benefit)338,176(15,867)(265,298)44,936295,6961,001,404
Income (loss) from continuing operations:(1,162,251)68,962833,494(164,232)(927,184)(3,369,613)
Loss before gain (loss) on sale of properties:(164,232)(927,184)(3,369,613)
Net income (loss) available to common stockholders, diluted:(1,162,251)68,962833,494(164,232)(927,184)(3,369,613)

Comprehensive Income ($ in thousands)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
Net income (loss):(1,162,251)68,962833,494(164,232)(927,184)(3,369,613)
Other comprehensive income (loss)35,49058,470378,392(311,828)(225,530)(132,303)
Comprehensive income (loss), net of tax, attributable to parent:(1,126,761)127,4321,211,886(476,060)(1,152,714)(3,501,916)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: